S100A13 antibody
Principal name
S100A13 antibody
Alternative names for S100A13 antibody
S100-A13, S100 calcium-binding protein A13
Ncbi ID
9606, NP_005970, NP_001019381, NM_005979, NM_001024210, NM_001024211, NM_001024212, NM_001024213, NP_001019382, NP_001019384, NP_001019383, NP_001019381.1, NM_009113, NP_033139.1
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB), ELISA (detection) (E(detection)), EPair for Elisa (EPair), Paraffin Sections (P)
Background of S100A13 antibody
- Kit Component:
- - KN210001G1, S100A13 gRNA vector 1 in pCas-Guide vector
- KN210001G2, S100A13 gRNA vector 2 in pCas-Guide vector
- KN210001D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Mandinova A., et al. (2003) Cell Sci. 116:2687-2696.
Immunofluorescence of monoclonal antibody to S100A13 on HeLa cell. [antibody concentration 10 ug/ml]
Western Blot analysis of S100A13 expression in transfected 293T cell line by S100A13 monoclonal antibody (M01), clone 3A7.Lane 1: S100A13 transfected lysate(11.5 KDa).Lane 2: Non-transfected lysate.
S100A13 monoclonal antibody (M01), clone 3A7 Western Blot analysis of S100A13 expression in MCF-7 ( Cat # L046V1 ).
Detection limit for recombinant GST tagged S100A13 is approximately 0.1ng/ml as a capture antibody.
Immunofluorescence of purified MaxPab antibody to S100A13 on HeLa cell. [antibody concentration 10 ug/ml]
Western Blot analysis of S100A13 expression in transfected 293T cell line (H00006284-T01) by S100A13 MaxPab polyclonal antibody.Lane 1: S100A13 transfected lysate(10.78 KDa).Lane 2: Non-transfected lysate.
S100A13 MaxPab polyclonal antibody. Western Blot analysis of S100A13 expression in HepG2.
S100A13 MaxPab rabbit polyclonal antibody. Western Blot analysis of S100A13 expression in human kidney.
Western Blot analysis of S100A13 expression in transfected 293T cell line (H00006284-T01) by S100A13 MaxPab polyclonal antibody.Lane 1: S100A13 transfected lysate(11.50 KDa).Lane 2: Non-transfected lysate.
Recombinant human S100A13, 1-98aa, His-tagged
The image on the left is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using (S100A13 Antibody) at dilution 1/35, on the right is treated with synthetic peptide. (Original magnification: ×200)
The image on the left is immunohistochemistry of paraffin-embedded Human prostate cancer tissue using (S100A13 Antibody) at dilution 1/35, on the right is treated with synthetic peptide. (Original magnification: ×200)
Gel: 12%SDS-PAGE,Lysate: 40 ug,,Primary antibody: (S100A13 Antibody) at dilution 1/200 dilution,Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution,Exposure time: 2 minutes
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA351618 | S100A13 antibody |
||||||
| Rabbit Polyclonal Anti-S100A13 Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu | E, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA351619 | S100A13 antibody |
||||||
| Rabbit Polyclonal Anti-S100A13 Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
 +1 additional image |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP310001 | S100A13 (transcript variant 1) |
||||
| Purified recombinant protein of Homo sapiens S100 calcium binding protein A13 (S100A13), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP311660 | S100A13 (transcript variant 3) |
||||
| Purified recombinant protein of Homo sapiens S100 calcium binding protein A13 (S100A13), transcript variant 3 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP311720 | S100A13 (transcript variant 5) |
||||
| Purified recombinant protein of Homo sapiens S100 calcium binding protein A13 (S100A13), transcript variant 5 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP318914 | S100A13 (transcript variant 4) |
||||
| Purified recombinant protein of Homo sapiens S100 calcium binding protein A13 (S100A13), transcript variant 4 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP322165 | S100A13 (transcript variant 2) |
||||
| Recombinant protein of human S100 calcium binding protein A13 (S100A13), transcript variant 2 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| PR15076CF-50 | S100A13 (Carrier Free) |
||||
 |
Human | Purified | > 97 % | E. coli |
50 µg /
€400.00
|
| Neuromics Antibodies | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY416946 | S100A13 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY422618 | S100A13 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY422619 | S100A13 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY422620 | S100A13 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY422621 | S100A13 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY425441 | S100A13 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY425442 | S100A13 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY425443 | S100A13 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY425444 | S100A13 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR218324L2V | Lenti ORF particles, S100a13 (GFP-tagged) - Mouse S100 calcium binding protein A13 (S100a13), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR218324L1V | Lenti ORF particles, S100a13 (Myc-DDK-tagged) - Mouse S100 calcium binding protein A13 (S100a13), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||